Triple advantages of injectable long acting second generation antipsychotics: Relapse prevention, neuroprotection, and lower mortality

Schizophr Res. 2018 Jul:197:69-70. doi: 10.1016/j.schres.2018.02.004. Epub 2018 Mar 3.

Author

Henry A Nasrallah¹

Affiliation

¹ Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, Saint Louis, MO, USA. Electronic address: henry.nasrallah@uc.edu.

PMID: 29506767
DOI: 10.1016/j.schres.2018.02.004

No abstract available

Keywords: Mortality; Neuroprotection; Relapse prevention; Schizophrenia; Second generation injectable antipsychotics.

Publication types

Comment

MeSH terms

Antipsychotic Agents*
Humans
Medication Adherence
Neuroprotection
Schizophrenia*
Secondary Prevention

Substances

Antipsychotic Agents